Follicular lymphoma grade IIIb, intrapelvic lymph nodes
ICD-10 C82.46 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiib, intrapelvic lymph nodes.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade IIIb indicates a more aggressive form of the disease, where there is a predominance of large cells, often leading to a more rapid progression. In this case, the lymphoma is localized to the intrapelvic lymph nodes, which can include nodes in the iliac, inguinal, and pelvic regions. Patients may present with B-symptoms such as fever, night sweats, and weight loss, which are indicative of systemic involvement. Diagnosis typically involves imaging studies such as CT scans and biopsy of affected lymph nodes. Treatment protocols may include chemotherapy, immunotherapy, or radiation therapy, depending on the stage and symptoms. The prognosis can vary significantly based on the grade and extent of the disease, with grade IIIb generally associated with a poorer prognosis compared to lower grades.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Diagnosis and management of newly diagnosed follicular lymphoma, treatment planning for relapsed disease.
Accurate staging and grading are crucial for treatment decisions and prognosis.
Clear imaging reports indicating the size and location of lymph nodes.
CT or PET scans for staging and monitoring treatment response.
Imaging findings must correlate with clinical symptoms and pathology results.
Used for patients receiving chemotherapy for follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists must ensure accurate coding of chemotherapy sessions.
Common treatments include chemotherapy regimens such as R-CHOP, immunotherapy with monoclonal antibodies, and radiation therapy, depending on the patient's overall health and disease stage.
